US Patent Issued to INSTITUTE FOR CANCER RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER on April 7 for "Treatment of tumors with miRNA targeting CDK4/CDK6" (Pennsylvania Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,483, issued on April 7, was assigned to INSTITUTE FOR CANCER RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER (Philadelphia).

"Treatment of tumors with miRNA targeting CDK4/CDK6" was invented by Amriti R. Lulla (Philadelphia) and Wafik S. El-Deiry (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides miRNA mimics targeting CDK4 and/or CDK6, and compositions comprising the same. Methods for the treatment of tumors, including but not limited to colon cancer, comprising administering a modified oligonucleotide comprising a miRNA are also disclosed herein."

The patent was filed on Nov. 16, 2023, under Application No....